NGC - Search Results

Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

NGC Search Results

Search Help | Guideline Comparison Help | Guideline Views | Quick Search Tips

Your search criteria:

Disease/Condition: "breast neoplasms" OR "breast cancer"
Guideline Categories: Management, Treatment
Sort Order: Relevance

Your search found 40 related guidelines, which are listed below by relevance. Use the "Limit Search" button to sort by publication date.

To view a guideline summary, click on a title below.

Items 1 to 20

	Title
	The role of the taxanes in the management of metastatic breast cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2003 Apr 24. 31 pages. NGC:003052 Other Guidelines from this Developer
	Management of ductal carcinoma in situ of the breast: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 1998 Jan 20 (revised 2006 Sep 19). 41 pages. NGC:005344 Other Guidelines from this Developer
	Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2003 May. 28 pages. NGC:004910 Other Guidelines from this Developer
	Common breast problems. University of Michigan Health System - Academic Institution. 2007 Oct. 10 pages. NGC:006199 Other Guidelines from this Developer
	Oncology evidence-based nutrition practice guideline. American Dietetic Association - Professional Association. 2007 Oct. Various pagings. NGC:006621 Other Guidelines from this Developer
	American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. American Society of Clinical Oncology - Medical Specialty Society. 2005 Oct 20. 18 pages. NGC:004562 Other Guidelines from this Developer
	The role of gemcitabine in the management of metastatic breast cancer: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2006 Jun 27 (revised 2007 Jan 22). 35 pages. NGC:005583 Other Guidelines from this Developer
	Surgical management of early stage invasive breast cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 1996 Feb 14 (revised January 2003) . 20 pages. NGC:002932 Other Guidelines from this Developer
	Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Nov. 37 pages. NGC:005407 Other Guidelines from this Developer
	Epirubicin, as a single agent or in combination, for metastatic breast cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 1997 Mar 11 (updated online 2003 Apr 30). 15 pages. NGC:003344 Other Guidelines from this Developer
	Capecitabine in stage IV breast cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2003 Nov 26. 17 pages. NGC:003351 Other Guidelines from this Developer
	The role of taxanes in neoadjuvant chemotherapy for women with non-metastatic breast cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2004 Dec 10. 32 pages. NGC:004003 Other Guidelines from this Developer
	Ductal carcinoma in situ. American College of Radiology - Medical Specialty Society. 1996 (revised 2006). 15 pages. NGC:005130 Other Guidelines from this Developer
	Breast cancer. National Committee on Cancer Care (Singapore) - National Government Agency [Non-U.S.] Singapore Ministry of Health - National Government Agency [Non-U.S.]. 2004 Mar. 72 pages. NGC:003619 Other Guidelines from this Developer
	Management of breast cancer in women. A national clinical guideline. Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. 1998 Oct (revised 2005 Dec). 50 pages. NGC:004745 Other Guidelines from this Developer
	Gemcitabine for the treatment of metastatic breast cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 24 pages. NGC:005740 Other Guidelines from this Developer
	Diagnosis of breast disease. Institute for Clinical Systems Improvement - Private Nonprofit Organization. 1994 Jan (revised 2008 Jan). 47 pages. NGC:006317 Other Guidelines from this Developer
	The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: guideline recommendations. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2005 Oct 25 (revised 2008 Feb 26). 49 pages. NGC:006433 Other Guidelines from this Developer
	Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Aug. 23 pages. NGC:005736 Other Guidelines from this Developer
	Paclitaxel for the adjuvant treatment of early node-positive breast cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Sep. 18 pages. NGC:005737 Other Guidelines from this Developer

Browse

» Disease / Condition
» Treatment / Intervention
» Measures
» Organization
» Guideline Index
» Guidelines In Progress
» Guideline Archive

Compare

» View My Collection
» Guideline Syntheses

Search
Browse
Compare
Resources

Date Modified: 1/12/2009